Back to Directory

Sean Brummel

Email

sbrummel@sdac.harvard.edu

Institution

SDAC/Harvard School of Public Health

Address

SDAC/Harvard School of Public Health
651 Huntington Avenue
FXB Building, Room 549A
Boston, MA 02115

Request an Update

Affiliated Studies

IMPAACT 2024 : Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV

DAIDS Number

Research Area

Study Status

IMPAACT 2050: Phase IV Study of the Pharmacokinetics of Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnant and Postpartum Women with HIV in the United States

DAIDS Number

Research Area

Study Status

IMPAACT 2040: Phase I/II Study of the Pharmacokinetics and Safety of Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnant and Postpartum Women with HIV-1

DAIDS Number

Research Area

Study Status

1077BF: PROMISE 1077BF

DAIDS Number

Research Area

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2010: VESTED

DAIDS Number

Research Area

Study Status

Participants Off Study and Primary Analysis Completed

Show All